Angiotensin Converting Enzyme 2 (ace2) - Infectious Diseases

Relevant Publications

Computational discovery of dual potential inhibitors of SARS-CoV-2 spike/ACE2 and M: 3D-pharmacophore, docking-based virtual screening, quantum mechanics and molecular dynamics.

Issue Release: 2024

A broad neutralizing nanobody against SARS-CoV-2 engineered from an approved drug.

Issue Release: 2024

Density functional theory and enzyme studies support interactions between angiotensin receptor blockers and angiotensin converting enzyme-2: Relevance to coronavirus 2019.

Issue Release: 2024

Computational design and investigation of the monomeric spike SARS-CoV-2-ferritin nanocage vaccine stability and interactions.

Issue Release: 2024

Receptors Involved in COVID-19-Related Anosmia: An Update on the Pathophysiology and the Mechanistic Aspects.

Issue Release: 2024

Biosensor-based active ingredient recognition system for screening potential small molecular Severe acute respiratory syndrome coronavirus 2 entry blockers targeting the spike protein from Rugosa rose.

Issue Release: 2024

Anti-SARS-CoV-2 Viral Activity of Sweet Potato Trypsin Inhibitor via Downregulation of TMPRSS2 Activity and ACE2 Expression In Vitro and In Vivo.

Issue Release: 2024

Enveloped Viral Replica Equipped with Spike Protein Derived from SARS-CoV-2.

Issue Release: 2024

The flavonoid quercetin decreases ACE2 and TMPRSS2 expression but not SARS-CoV-2 infection in cultured human lung cells.

Issue Release: 2024

Systematic Studies on the Anti-SARS-CoV-2 Mechanisms of Tea Polyphenol-Related Natural Products.

Issue Release: 2024

Heparin-mediated PCR interference in SARS-CoV-2 assays and subsequent reversal with heparinase I.

Issue Release: 2024

Novel benzimidazole angiotensin receptor blockers with anti-SARS-CoV-2 activity equipotent to that of nirmatrelvir: computational and enzymatic studies.

Issue Release: 2024

A Rationally Designed Synthetic Antiviral Peptide Binder Targeting the Receptor-Binding Domain of SARS-CoV-2.

Issue Release: 2024

A Host Receptor Nanodisc-Based Biosensor Platform for the Detection of a Specific Virus and Its Variants.

Issue Release: 2024

Development of a mutant aerosolized ACE2 that neutralizes SARS-CoV-2 .

Issue Release: 2024

Single Ferritin Nanocages Expressing SARS-CoV-2 Spike Variants to Receptor and Antibodies.

Issue Release: 2024

Molecular modeling of some commercially available antiviral drugs and their derivatives against SARS-CoV-2 infection.

Issue Release: 2024

Food-Derived Up-Regulators and Activators of Angiotensin Converting Enzyme 2: A Review.

Issue Release: 2024

Glycosylation Modulation Dictates Trafficking and Interaction of SARS-CoV-2 S1 Subunit and ACE2 in Intestinal Epithelial Caco-2 Cells.

Issue Release: 2024

Effects of sEH inhibition on the eicosanoid and cytokine storms in SARS-CoV-2-infected mice.

Issue Release: 2024

Why Do Infectious Diseases Cause Muscle Aches?

How are Structural Proteins Targeted in Vaccine Development?

Is there a Vaccine for West Nile Virus?

How is Chlamydia Treated?

How Does Parasite DNA Contribute to Drug Resistance?

What are the Global Implications?

How is Neisseria gonorrhoeae transmitted?

How to Interpret Chest CT Scan Results?

How are Infectious Diseases Treated?

How Can Technology Help?

Partnered Content Networks

Relevant Topics